TNF inhibitors vs JAK inhibitors: what’s the head-to-head study state of play? (**efficacy not safety, non-real life data of course) #EULAR2019 Gerd Burmester on ‘The wind of change in RA’ @RheumNow https://t.co/zK1wqskmLc